These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36481407)

  • 1. New light on treatment of cervical cancer: Chinese medicine monomers can be effective for cervical cancer by inhibiting the PI3K/Akt signaling pathway.
    Liu F; Xu J; Yang R; Liu S; Hu S; Yan M; Han F
    Biomed Pharmacother; 2023 Jan; 157():114084. PubMed ID: 36481407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Li YJ; Wang Y; Wang YY
    J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P; Jiao Y; Hao M; Tang X
    J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
    Duan W; Liu X
    Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A literature review on signaling pathways of cervical cancer cell death-apoptosis induced by Traditional Chinese Medicine.
    Peng C; Wang Y; Guo Y; Li J; Liu F; Fu Y; Yu Y; Zhang C; Fu J; Han F
    J Ethnopharmacol; 2024 Nov; 334():118491. PubMed ID: 38936644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
    Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
    J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRC5 promotes tumorigenesis by regulating the PI3K/AKT signaling pathway in cervical cancer.
    Ling L; Chen J; Zhan L; Fu J; He R; Wang W; Wei B; Ma X; Cao Y
    Sci Rep; 2024 Jul; 14(1):15353. PubMed ID: 38961101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating PI3K/Akt signaling pathway.
    Jiang D; Ren C; Yang L; Li F; Yang X; Zheng Y; Ji X; Tian Y
    J Obstet Gynaecol Res; 2021 Jul; 47(7):2433-2441. PubMed ID: 34028125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant-Derived Chinese Medicine Monomers on Ovarian Cancer via the Wnt/
    Xu JY; Liu FY; Liu SX; Xie LZ; Li J; Ma YT; Han FJ
    J Oncol; 2021; 2021():6852867. PubMed ID: 34912456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway.
    Fu K; Zhang L; Liu R; Shi Q; Li X; Wang M
    World J Surg Oncol; 2020 May; 18(1):115. PubMed ID: 32473637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
    Yang W; Xie T
    Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway.
    Lu X; Song X; Hao X; Liu X; Zhang X; Yuan N; Ma H; Zhang Z
    Bioengineered; 2021 Dec; 12(1):7079-7092. PubMed ID: 34551673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.
    Chen L; Qing J; Xiao Y; Huang X; Chi Y; Chen Z
    BMC Cancer; 2022 Apr; 22(1):370. PubMed ID: 35392845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-cervical cancer effects of Compound Yangshe granule through the PI3K/AKT pathway based on network pharmacology.
    Ma C; Gu Y; Liu C; Tang X; Yu J; Li D; Liu J
    J Ethnopharmacol; 2023 Jan; 301():115820. PubMed ID: 36220511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer activity of Eremanthin against the human cervical cancer cells is due to G2/M phase cell cycle arrest, ROS-mediated necrosis-like cell death and inhibition of PI3K/AKT signalling pathway.
    Liu T; Zhao X; Song D; Liu Y; Kong W
    J BUON; 2020; 25(3):1547-1553. PubMed ID: 32862603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydrocostus Lactone Inhibits Proliferation, Antiapoptosis, and Invasion of Cervical Cancer Cells Through PI3K/Akt Signaling Pathway.
    Jiang E; Sun X; Kang H; Sun L; An W; Yao Y; Hu X
    Int J Gynecol Cancer; 2015 Sep; 25(7):1179-86. PubMed ID: 26017248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
    Zhang X; Liu S; Zhu Y
    Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑433 inhibits cell growth and induces apoptosis in human cervical cancer through PI3K/AKT signaling by targeting FAK.
    Xu J; Zhu W; Chen L; Liu L
    Oncol Rep; 2018 Dec; 40(6):3469-3478. PubMed ID: 30272334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucoxanthin induces apoptosis in human cervical cancer cell line HeLa via PI3K/Akt pathway.
    Ye G; Lu Q; Zhao W; Du D; Jin L; Liu Y
    Tumour Biol; 2014 Nov; 35(11):11261-7. PubMed ID: 25113250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.